ZA200804010B - Carbamate compounds as 5-HT4 receptor agonists - Google Patents

Carbamate compounds as 5-HT4 receptor agonists

Info

Publication number
ZA200804010B
ZA200804010B ZA200804010A ZA200804010A ZA200804010B ZA 200804010 B ZA200804010 B ZA 200804010B ZA 200804010 A ZA200804010 A ZA 200804010A ZA 200804010 A ZA200804010 A ZA 200804010A ZA 200804010 B ZA200804010 B ZA 200804010B
Authority
ZA
South Africa
Prior art keywords
receptor agonists
carbamate compounds
carbamate
compounds
agonists
Prior art date
Application number
ZA200804010A
Other languages
English (en)
Inventor
Long Daniel
Paul R Fatheree
Marquess Daniel
Choi Seok-Ki
Goldblum Adam
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of ZA200804010B publication Critical patent/ZA200804010B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200804010A 2005-11-22 2008-05-09 Carbamate compounds as 5-HT4 receptor agonists ZA200804010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73870205P 2005-11-22 2005-11-22

Publications (1)

Publication Number Publication Date
ZA200804010B true ZA200804010B (en) 2009-02-25

Family

ID=38067868

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804010A ZA200804010B (en) 2005-11-22 2008-05-09 Carbamate compounds as 5-HT4 receptor agonists

Country Status (20)

Country Link
US (2) US7329752B2 (xx)
EP (1) EP1960396B1 (xx)
JP (1) JP2009516745A (xx)
KR (1) KR20080072727A (xx)
CN (1) CN101312967B (xx)
AR (1) AR057627A1 (xx)
AT (1) ATE448224T1 (xx)
AU (1) AU2006318507A1 (xx)
BR (1) BRPI0618835A2 (xx)
CA (1) CA2630222A1 (xx)
DE (1) DE602006010432D1 (xx)
EA (1) EA014819B1 (xx)
ES (1) ES2336952T3 (xx)
MY (1) MY143574A (xx)
NO (1) NO20082597L (xx)
NZ (1) NZ567653A (xx)
PE (1) PE20070954A1 (xx)
TW (1) TW200804366A (xx)
WO (1) WO2007062058A2 (xx)
ZA (1) ZA200804010B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560828A (en) * 2005-03-02 2011-01-28 Theravance Inc Quinolinone compounds as 5-HT4 receptor agonists
CA2637214C (en) * 2006-02-16 2014-04-22 Theravance, Inc. Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
IT1231413B (it) 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
JP3829879B2 (ja) 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
US6069152A (en) 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
IT1298271B1 (it) 1998-02-18 1999-12-20 Boehringer Ingelheim Italia Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
EP1173168A2 (en) 1999-04-28 2002-01-23 Respiratorius AB Compound for use as a medicament for treatment of disorders involving bronchocontraction
IT1313625B1 (it) 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
JP4181847B2 (ja) * 2002-10-25 2008-11-19 エルピーダメモリ株式会社 タイミング調整回路、半導体装置及びタイミング調整方法
OA13248A (en) 2003-09-03 2007-01-31 Pfizer Benzimidazolone coumpounds having 5-HT4 receptor agonistic activity.
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
DE602005016446D1 (de) 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
DE602005014566D1 (de) * 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
CA2588037A1 (en) 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
NZ560828A (en) 2005-03-02 2011-01-28 Theravance Inc Quinolinone compounds as 5-HT4 receptor agonists
US7351304B2 (en) * 2005-05-24 2008-04-01 General Electric Company Method and apparatus for reducing surface defects
JP5086248B2 (ja) 2005-06-07 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物

Also Published As

Publication number Publication date
US20070117796A1 (en) 2007-05-24
CN101312967B (zh) 2011-08-24
EA014819B1 (ru) 2011-02-28
BRPI0618835A2 (pt) 2011-09-13
MY143574A (en) 2011-05-31
CA2630222A1 (en) 2007-05-31
NO20082597L (no) 2008-06-10
PE20070954A1 (es) 2007-09-10
EP1960396B1 (en) 2009-11-11
DE602006010432D1 (de) 2009-12-24
NZ567653A (en) 2011-06-30
EP1960396A2 (en) 2008-08-27
ES2336952T3 (es) 2010-04-19
CN101312967A (zh) 2008-11-26
US7329752B2 (en) 2008-02-12
US7851467B2 (en) 2010-12-14
US20080090811A1 (en) 2008-04-17
WO2007062058A2 (en) 2007-05-31
JP2009516745A (ja) 2009-04-23
KR20080072727A (ko) 2008-08-06
EA200801402A1 (ru) 2008-10-30
ATE448224T1 (de) 2009-11-15
AU2006318507A1 (en) 2007-05-31
AR057627A1 (es) 2007-12-05
WO2007062058A3 (en) 2007-09-07
TW200804366A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
IL178086A0 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
IL177059A0 (en) Indazole-carboxamide compounds as 5-ht4 receptor agonists
IL186883A0 (en) Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
HK1135966A1 (en) Oxyindole derivatives as 5ht4 receptor agonists
IL188550A0 (en) Heterocyclic compounds as agonists for the thyroid receptor
ZA200800320B (en) Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
IL186150A0 (en) Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists
ZA200709086B (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
EP1931632A4 (en) USEFUL INDOOR CONNECTIONS
AP2007004047A0 (en) Substituted triazole derivatives as oxtocin antagonists
SG158918A1 (en) 2-phenyl-indoles as prostaglandin d2 receptor antagonists
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
AP2007004171A0 (en) Novel compounds
EP1868612A4 (en) NOVEL CONNECTIONS
EP1868611A4 (en) NOVEL CONNECTIONS
ZA200707142B (en) Quinolinone compounds as 5-HT4 receptor agonists
IL185640A0 (en) Use of 2-anilino-3 ,4-dihydro-quinazolines as 5ht5a receptor antagonists
EP1869026A4 (en) NEW CONNECTIONS
ZA200804010B (en) Carbamate compounds as 5-HT4 receptor agonists
GB0525029D0 (en) Receptor Antagonist
ZA200709829B (en) Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
GB0516946D0 (en) Receptor
GB0510253D0 (en) Receptor
GB0522394D0 (en) Receptor
GB0522077D0 (en) Receptor